Items Tagged with 'CORE'

The latest Annual Report from the Office of Coordinated Outbreak Response, Evaluation, and Emergency Preparedness (CORE+EP) summarizes its response to outbreaks and adverse events associated with FDA-regulated human foods, and details notable incidents.

FDA’s CORE+EP team conducts outbreak surveillance, investigation, mitigation, and post-response initiatives for products regulated by the Human Foods Program, including the analysis of outbreak data for food safety decision-making and sharing outbreak findings with food safety stakeholders. 

The agency’s Office of Coordinated Outbreak Response, Evaluation, and Emergency Preparedness (CORE+EP) evaluated 72 incidents, initiated 26 response investigations, and issued ten public health advisories in 2024.

This article provides background information about FDA’s CORE+EP Signals team's day-to-day work in detecting foodborne illness outbreaks and triaging incidents, and highlights some real-world examples and partnerships that have occurred to improve food safety and protect consumers.

An aim of FDA's Coordinated Outbreak Response, Evaluation, and Emergency Preparedness Office (CORE+EP) is to share the findings of foodborne illness outbreak investigations, highlighting relevant topics such as the importance of global partnerships in farm investigations and the benefits of historical environmental surveillance for future outbreak investigations. 

Ice cream has historically been associated with human cases of infection by various foodborne pathogens. Pathogen introduction into ice cream can occur at various points throughout the production process for a range of reasons, which can be addressed through proper food safety controls. 

The primary role of FDA's Coordinated Outbreak Response and Evaluation (CORE) Network is to conduct outbreak surveillance, manage the response efforts, and initiate post-outbreak activities for incidents involving FDA-regulated products. This article explores the evolution, work, and perpetual improvement of the CORE Network.

The U.S. Food and Drug Administration (FDA) has released the CORE 2022 Annual Report—the first report of its kind—summarizing the investigations of foodborne illness outbreaks and adverse events involving FDA-regulated foods conducted by the Coordinated Outbreak Response and Evaluation (CORE) Network. 

Salmonella spp. have long been associated with low-moisture foods such as nuts and nut-derived products, with varying prevalence observed in tree nuts, including cashews, at retail. Virtually all cashews are imported to the U.S. Some nuts, including cashews, are imported as a "raw" product (i.e., one that has not been subjected to a process to adequately reduce pathogens, such as a kill step). Salmonella contamination of such products has resulted in several notable outbreaks in the U.S. in the past ten years, including those in which cashew-containing products have been implicated as a vehicle. This article presents a brief overview of outbreak investigations of Salmonella infections linked to the consumption of cashews and cashew-containing food products. It also presents challenges encountered, lessons learned, and relevant regulatory requirements for importers and manufacturers of cashews and cashew-containing products.

Officials from the U.S. Food and Drug Administration (FDA) recently held a conversation to explain to stakeholders how the agency handles foodborne illness outbreaks and other adverse food safety events, as well as how FDA plans to improve its processes. FDA also released a supplementary video illustrating its processes.